Computer-aided detection developer Rcadia Medical Imaging of Haifa, Israel, has received the European CE Mark for its COR Analyzer, its proprietary software that helps identify patients with significant coronary artery disease by automatic analysis of coronary CT angiography (CTA) studies.
COR Analyzer is designed to process patient images from coronary CTA studies generated by all four manufacturers of 64-slice (and above) CT systems and produce results in real-time that determine whether significant lesions are present in major coronary arteries.
The software has already been cleared by the U.S. Food and Drug Administration.
Related Reading
Rcadia lands investment, December 16, 2008
Rcadia debuts COR Analyzer for coronary CTA, December 3, 2008
Rcadia adds distributor, November 20, 2007
Rcadia establishes U.S. beta site, October 30, 2007
Rcadia nets FDA nod, September 26, 2007
Copyright © 2010 AuntMinnie.com
